These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 15985372

  • 1. Semi-automated preparation of the dopamine transporter ligand [(18)F]FECNT for human PET imaging studies.
    Voll RJ, McConathy J, Waldrep MS, Crowe RJ, Goodman MM.
    Appl Radiat Isot; 2005 Sep; 63(3):353-61. PubMed ID: 15985372
    [Abstract] [Full Text] [Related]

  • 2. Potential of [(18)F]beta-CFT-FE (2beta-carbomethoxy-3beta-(4-fluorophenyl)-8-(2-[(18)F]fluoroethyl)nortropane) as a dopamine transporter ligand: A PET study in the conscious monkey brain.
    Harada N, Ohba H, Fukumoto D, Kakiuchi T, Tsukada H.
    Synapse; 2004 Oct; 54(1):37-45. PubMed ID: 15300883
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Synthesis and in vivo evaluation of fluorine-18 and iodine-123 labeled 2beta-carbo(2-fluoroethoxy)-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane as a candidate serotonin transporter imaging agent.
    Plisson C, Stehouwer JS, Voll RJ, Howell L, Votaw JR, Owens MJ, Goodman MM.
    J Med Chem; 2007 Sep 20; 50(19):4553-60. PubMed ID: 17705359
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synthesis and biodistribution of [18F]FE@CIT, a new potential tracer for the dopamine transporter.
    Mitterhauser M, Wadsak W, Mien LK, Hoepping A, Viernstein H, Dudczak R, Kletter K.
    Synapse; 2005 Feb 20; 55(2):73-9. PubMed ID: 15529336
    [Abstract] [Full Text] [Related]

  • 15. Improved synthesis and metabolic stability analysis of the dopamine transporter ligand [(18)F]FECT.
    Chitneni SK, Garreau L, Cleynhens B, Evens N, Bex M, Vermaelen P, Chalon S, Busson R, Guilloteau D, Van Laere K, Verbruggen A, Bormans G.
    Nucl Med Biol; 2008 Jan 20; 35(1):75-82. PubMed ID: 18158946
    [Abstract] [Full Text] [Related]

  • 16. (18)F-FECNT: validation as PET dopamine transporter ligand in parkinsonism.
    Masilamoni G, Votaw J, Howell L, Villalba RM, Goodman M, Voll RJ, Stehouwer J, Wichmann T, Smith Y.
    Exp Neurol; 2010 Dec 20; 226(2):265-73. PubMed ID: 20832405
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and biological evaluation of [11C]talopram and [11C]talsupram: candidate PET ligands for the norepinephrine transporter.
    McConathy J, Owens MJ, Kilts CD, Malveaux EJ, Camp VM, Votaw JR, Nemeroff CB, Goodman MM.
    Nucl Med Biol; 2004 Aug 20; 31(6):705-18. PubMed ID: 15246361
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Isoflurane induces dopamine transporter trafficking into the cell cytoplasm.
    Byas-Smith MG, Li J, Szlam F, Eaton DC, Votaw JR, Denson DD.
    Synapse; 2004 Aug 20; 53(2):68-73. PubMed ID: 15170819
    [Abstract] [Full Text] [Related]

  • 20. Availability of dopamine transporters in heroin-dependent subjects: A 18F-FECNT PET imaging study.
    Xu S, Liu Y, Li Y, Deng Y, Yuan J, Lv R, Wang Y, Zhang G, Guo Z, Fu D, Zeng H, Han M, Liu X.
    Psychiatry Res Neuroimaging; 2017 May 30; 263():121-126. PubMed ID: 28376406
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.